Animals have been kept as pets and for consumption since the beginning of time, and in most recent years for experimental purposes. Although most of the experiments performed on these animals are regarded as important for the furtherance of human and veterinary science, there is a strong movement from within the scientific community to develop methods that do not rely on animals.
Although we see many efforts in reducing animal suffering and animal experiments. It still may take a long time before we will be able to replace all animal experiments. Until such a time comes it is our responsibility to ensure every effort will be taken to reduce both the number and suffering of experimental animals.
Areas of Discussion:
- An in Depth Study of the 3R’s
- Relative and Absolute Replacement Models
- Difficulties of Extrapolating a Results to the Human Situation
- In Vitro Methods: Replacement or Addition to Animal testing
- Computer Modeling, Biochemical Techniques and In Vitro Methods
- The Refinement and Reduction of Suffering of Experimental Animals Before, During and After an Experiment and more…
Humane Science in the 21st Century
Protection of animals used for scientific purposes
Innovative alternative technologies and testing strategies
New approaches in testing of cosmetics
Advances in testing of pharmaceuticals and and chemicals
Refinement, reduction, and advanced disease models
The EuroQSAR Symposia have been taking place since 1973 and constitute the major scientific events in the field of computer-aided drug design & discovery, with further applications in agricultural and environmental sciences. The 2014 symposium will not only follow the tradition of previous events in presenting latest trends in QSAR and molecular modeling, it will also explore new grounds, such as integrated approaches and open innovation strategies in drug discovery. The 20th EuroQSAR symposium, entitled Understanding Chemical-Biological Interactions, will include 9 plenary lectures and 28 oral communications to be selected from the submitted abstracts and will focus on:
Chemical-Biological Space: Representation, Visualisation and Navigation
Chemo- and Bioinformatics Approaches to Multi-Target (Q)SAR
Modeling of Protein-Ligand Interactions: Structure, Function and Dynamics
Assessing Ligand Binding Kinetics
Computational Toxicology in Drug and Chemical Safety Assessment
Translational Bioinformatics: From Genomes to Drugs
Emerging QSAR and Modeling Methods
Presented by: The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) Physicians Committee for Responsible Medicine (PCRM)
To register, visit the workshop webpage at http://ntp.niehs.nih.gov/go/41374.
For more information contact NICEATM at 919-316-4668 or firstname.lastname@example.org.
Individuals with disabilities who need accommodation to participate in this event should contact Elizabeth Maull at 919-316-4668 or email@example.com. TTY users should contact the Federal TTY Relay Service at 800-877-8339. Requests should be made at least 5 days in advance of the event.
With additional support from the UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and the British Toxicology Society (BTS). This workshop provides funds for PhD students and Post-docs to visit Newcastle University for a workshop based around the use of a pancreatic progenitor cell (B-13) to generate hepatocyte-like cells in vitro. The workshop will be held either side of the 2014 Eurotox meeting in Edinburgh and will involve lectures and hands on experience of B-13 culture in the Wright lab (http://www.ncl.ac.uk/icm/people/profile/matthew.wright) prior to the Eurotox meeting. On the return visit, hepatocytes generated will be examined and/or harvested for analyses. In addition, attendees will be able to collect progenitors for use in their own labs.
The Conference aim is to “Advance Science for Human and Environmental Health” and we have an exciting programme highlighting new and innovative science and current regulatory topics. There will be a mix of plenary and keynote lectures, symposia, workshops and a full continuing education programme. In addition, there will be interactive poster sessions and a dynamic trade exhibition. EUROTOX 2014 will be THE meeting place for toxicologists from around the world to come together to meet and discuss the key issues facing the discipline today.
There will be an attractive social programme, including traditional music and a ceilidh. Edinburgh is an ideal base to explore the impressive beauty of the rest of Scotland. Please do come and join us in Edinburgh in 2014 and make this a dynamic and memorable conference.
The OpenTox Euro series of meetings emerged as a continuation of the EU-funded Health-FP7 project “OpenTox” which was completed successfully in August 2011. Our ambitious plan is to develop OpenTox further as an infrastructure and community with annual events held in Europe and the USA in the area of predictive toxicology and related fields.
EPA’s Second Data Summit: Beginning the Dialogue About Using New Data to Transform Chemical Safety Evaluations.
Data Summit Goal: Bring together the user community (industry, non-governmental organizations, academia, governmental agencies, and more) to present their ideas for using massive amounts of new chemical data, and begin a dialogue about how to implement these ideas to inform chemical policy and regulatory decisions.
The Annual Meeting provides an ideal venue for keeping abreast of emerging trends in the discipline of toxicology, for staying connected with friends and colleagues, and for making new connections. The people have spoken! While attendance at annual scientific meetings across industry is in a downward trend, ACT meetings continue to attract record-high attendance. This may be attributed to many things, but Council continues to ensure development of Symposia and Continuing Education courses that are directly applicable to the daily practice of toxicology. ACT is also a society whose size and culture offer consistent appeal to those who enjoy interacting personally with speakers, Council, and other colleagues in the field.
Animal Replacement Science 2014: Improving relevance to human disease - challenges, innovations and applications
There is increasing awareness of the challenges and limitations of using animals in research, not least of which are the issues associated with translating the results of such research to humans. Animal Replacement Science 2014 will focus up recent developments in animal replacement science and challenges in translating research for human relevancy. This inaugural meeting will consist of research presentations from invited speakers and those selected from submitted abstracts covering a wide range of scientific disciplines. The conference will include opportunities to view posters and will conclude with a panel-led discussion to explore the challenges, innovations and applications of animal replacement technology.
The European Society of Toxicology In Vitro (ESTIV) in collaboration with The Portuguese Toxicology Association (AP Tox) are pleased to announce that the ESTIV Applied in Vitro Toxicology Course that will take place in Lisbon, Portugal during 25th - 29th January 2015.
In vitro toxicity methods are gaining importance, in particular as a response to a number of European legislative changes which call for more mechanistically-based decision-making and limit or even prohibit the use of animal experimentation for risk assessment purposes. Hence, there is an urgent demand for toxicologists and risk assessors to implement in vitro testing results into regulatory safety evaluation of chemicals. This course aims at meeting this ubiquitous need by training individuals who wish to start or pursue a career in this direction or to gain an update on the state-of-the-art of applied in vitro toxicology.
This course is intended for (post)doctoral students and scientists from industry, academia or regulatory agencies who recently became active in the field of in vitro toxicology. Applicants should ideally have a background in toxicology, biology, chemistry, (bio)medical sciences, pharmaceutical sciences, veterinary sciences or equivalent. Attendees are expected to be proficient in English. A maximum of 25 participants will be enrolled in the course on a first-come/first-served basis, yet priority will be given to members of ESTIV, AP Tox and affiliated societies.
This 5-day course is organized by The European Society of Toxicology In Vitro (ESTIV) in collaboration with The Portugese Toxicology Association (AP Tox) and combines cutting-edge lectures by leading experts with highly interactive group exercises. The lectures cover a broad spectrum of subjects pertinent to regulatory, screening and investigative in vitro toxicology. The group exercises consist of real-life case studies in which the participants will apply the principles of in vitro toxicology to the risk assessment of chemical substances. Course examination will be based upon presentation and discussion of the case studies. The participants will receive a certificate in the case of a positive evaluation.
Driving the Big Science Challenge in Safety Forward co-chaired by Barry Hardy (Douglas Connect) and Thomas Hartung (John Hopkins). We will discuss and develop at this meeting important components for driving 21st century approaches to safety assessment forward. Their successful assembly and application will benefit greatly the health of our society and our environment and the private and public sector activities supporting those goals.